Oncological dispensary No. 2 of the Ministry of Health of the Krasnodar Territory
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kirtbaya, Dmitry
NCT06497036: Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia

Active, not recruiting
3
160
RoW
GP404141, romiplostim, Nplate, romilostim
Geropharm, Pharm-Holding, I.M. Sechenov First Moscow State Medical University
Drug Effect, Safety Issues, Immunogenicity
03/28
03/28
BRUIN CLL-321, NCT04666038: Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Active, not recruiting
3
250
Europe, Canada, Japan, US, RoW
LOXO-305, Pirtobrutinib, Idelalisib, Zydelig, Bendamustine, Treanda, Treakisym, Ribomustin, Levact, Rituximab, Rituxan, MabThera, Truxima
Loxo Oncology, Inc., Eli Lilly and Company
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
08/23
05/27
NEO-MIMAJOR, NCT05751928: A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

Recruiting
3
410
RoW
BCD-217, nurulimab+prolgolimab, anti-PD1, Excision of the primary lesion, Regional lymphadenectomy
Biocad
Melanoma Stage III, Melanoma (Skin)
01/27
06/27
Kirtbaya, DmitriI V
DARVIVA, NCT06296121: A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma

Recruiting
3
252
RoW
BCD-264, daratumumab, Darzalex
Biocad
Multiple Myeloma
01/25
07/26
OCTAVA, NCT05732805: A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

Recruiting
3
270
RoW
BCD-217, nurulimab+prolgolimab, BCD-100, prolgolimab, Forteca, Placebo
Biocad
Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Melanoma Unresectable, Melanoma Metastatic, Melanoma Advanced
04/24
04/25

Download Options